PCRX icon

PCRX

Lightning icon

23.97 USD

+1.16%

Today

-0.84%

1D

Market is closed

Sun

Closed

Mon

4:30 PM ~ 11:00 PM

Tue

4:30 PM ~ 11:00 PM

Wed

4:30 PM ~ 11:00 PM

Thu

4:30 PM ~ 11:00 PM

Fri

4:30 PM ~ 11:00 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Pacira Pharmaceuticals Leveraged

Currency

USD

Standard Leverage

1X

Lightning Icon

Enhanced Leverage

3X

Lightning Icon

Overnight Fees Buy

-0.0191%

Overnight Fees Sell

0.0024%

Market Cap

976.58M

Avg Daily Volume

748.38K

52 Week High

27.64 USD

52 Week Low

18.8 USD

Trading Hours

See hours

Overnight Fees Calculator

ExposureUnits
USD
Daily Overnight Fee %Daily Overnight Fee $
BUYS-0.01910%$(0.191)
SELLS0.00240%$0.024

*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.

Business Summary

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Top News

Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

tradingview.com

2d ago

No Image

Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting

tradingview.com

1w ago

No Image

AmAirlines

-0.53%

Adobe

-1.89%

AresManagement

-4.10%

Bumble

-1.45%

Blackstone

-1.66%

ConAgra

-2.19%

Pathward.Financial

-0.07%

Celanese

+0.84%

CFIndustries

+1.73%

CNX_Resources

+1.01%

Campbell_Soup

-1.73%

Customers.Bancorp

-1.61%

Chevron

-0.53%

Delta

-0.16%

DollarGeneral

-3.20%

DowChemical

+2.58%

EQT_Corp

-1.26%

GlobalFoundries

+0.16%

General_Mills

-3.29%

Jabil

+2.13%

KKR&Co

-1.65%

Cheniere

-0.08%

Southwest

-1.74%

MercadoLbr

-1.16%

Mosaic

-2.06%

MurphyOil

+2.80%

Northern-Oil

-0.96%

Natera

-5.47%

Oddity.Tech

+6.00%

Pacira

-0.84%

SM_Energy

+0.14%

UnitedCon

-1.32%

ExxonMobil

-1.24%

BUZZ-U.S. STOCKS ON THE MOVE -Gyre Therapeutics, Nutrien Ltd, Rapid Micro Biosystems

reuters.com

0mo ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.


Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.


What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.


What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.